Academia | Chemical & Engineering News
Volume 87 Issue 32 | p. 46 | Promotion
Issue Date: August 10, 2009


Department: ACS News
Keywords: people

Stephen Fesik has joined Vanderbilt University Medical Center as professor of biochemistry. He will lead the cancer drug discovery initiatives of the Vanderbilt Institute of Chemical Biology and the Vanderbilt-Ingram Cancer Center. Fesik had been a divisional vice president of cancer research at Abbott Laboratories, building a pipeline of drug candidates showing promising anticancer activity.


Susan J. Ainsworth compiles this section. Announcements of promotions, new hires, and retirements may be sent to

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment